LAUNXP Biomedical Co., Ltd
6876
Rank in Stocks
#25094
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Share Price
$0.40696752
Last synced: 2026-11-10
Market Cap
$28.30M
Change (1 day)
-4.64%
Change (1 year)
-45.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade LAUNXP Biomedical Co., Ltd (6876)
Category
Healthcare
Operating Margin for LAUNXP Biomedical Co., Ltd (6876)
Operating Margin as of November 2026 TTM: -18,183.33%
According to LAUNXP Biomedical Co., Ltd's latest financial reports, its current operating margin (TTM) is -18,183.33%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for LAUNXP Biomedical Co., Ltd from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -18,183.33% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -3,313.37% | -99.55% |
| 2023 | -736,809.09% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -3,583.50% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -99.99% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about LAUNXP Biomedical Co., Ltd's operating margin
What is LAUNXP Biomedical Co., Ltd's operating margin?
LAUNXP Biomedical Co., Ltd's operating margin is -18,183.33%, as of Nov 2026.
What was LAUNXP Biomedical Co., Ltd's operating margin in 2025?
In 2025, LAUNXP Biomedical Co., Ltd's operating margin was 0.00%, compared with -3,313.37% in 2024.
How has LAUNXP Biomedical Co., Ltd's operating margin changed since 2020?
From 2020 to 2025, LAUNXP Biomedical Co., Ltd's operating margin was highest in 2025 (0.00%) and lowest in 2023 (-736,809.09%).
How does LAUNXP Biomedical Co., Ltd's operating margin compare with similar companies?
LAUNXP Biomedical Co., Ltd's operating margin (-18,183.33%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.